Kinetics of omega-3 polyunsaturated fatty acids when co-administered with saturated or omega-6 fats.

Related Articles

Kinetics of omega-3 polyunsaturated fatty acids when co-administered with saturated or omega-6 fats.

Metabolism. 2015 Aug 28;

Authors: Dias CB, Wood LG, Phang M, Garg ML

Abstract
OBJECTIVE: Absorption of long chain omega-3 polyunsaturated fatty acids (LCn-3PUFA) has been shown to be potentiated when consumed with a high fat meal. However, the effect of different dietary fats on n-3PUFA absorption and postprandial kinetics has not been previously studied.
METHOD: In a randomized cross-over design intervention, postprandial incorporation of LCn-3PUFA into plasma lipids following consumption of a meal rich in either saturated fat or omega-6 polyunsaturated fatty acids (n-6PUFA) was investigated. Healthy adult male and female subjects (n=26) were fed an isocaloric meal containing equivalent amount of either butter or sunflower seed oil supplemented with 1.8grams of LCn-3PUFA (300mg eicosapentaenoic acid, 20:5n-3 and 1500mg docosahexaenoic acid, 22:6n-3).
RESULTS: Postprandial plasma lipids were enriched with saturated fatty acids and linoleic acid (18:2n-6) following consumption of the butter and the sunflower oil containing meals respectively. The increase in plasma 20:5n-3 and 22:6n-3 levels over the 6hour study period was similar in both the saturated and the n-6 fat groups.
CONCLUSION: These results suggest that the expected competition between LCn-3PUFA and n-6PUFA at the absorption level is unlikely; therefore competition at the enzymatic level should be primarily responsible for differences in their metabolic and clinical effects. Trial registered with the Australia New Zealand Trial registry as ACTRN12612000654853.

PMID: 26386693 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Old asthma drug reverses obesity, diabetes and fatty liver in mice – Examiner.com

Old asthma drug reverses obesity, diabetes and fatty liver in mice
Examiner.com
Alan Saltiel, the Mary Sue Coleman director of the Life Sciences Institute at the University of Michigan, reported the discovery that an off-patent drug currently prescribed for the treatment of asthma also reverses obesity, diabetes and fatty liver in
Old drug may point the way to new treatments for diabetes and obesityEurekAlert (press release)

all 2 news articles »

View full post on asthma – Google News